A case with congenital disorder of glycosylation with defective fucosylation 2 and new mutation in FUK gene
dc.authorid | Nezir Özgün / 0000-0002-0866-2004 | en_US |
dc.authorscopusid | Nezir Özgün / 57190179626 | |
dc.authorwosid | Nezir Özgün / GCT-0294-2022 | |
dc.contributor.author | Özgün, Nezir | |
dc.contributor.author | Şahin, Yavuz | |
dc.date.accessioned | 2021-11-26T10:42:18Z | |
dc.date.available | 2021-11-26T10:42:18Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Introduction: Congenital disorders of glycosylation (CDG) is a group of rare, hereditary, multisystem disorders, predominantly affecting nervous system. There are N- and O- types of glycosylation. Fucosylation, a form of N-glycosylation, involves many enzymes. Until today, type 1 and type 2 fucosylation defects were identified, having pathogenic variants in genes encoding ?-1,6-fucosyltransferase and fucokinase enzymes, respectively. In this article, a patient with type 2 fucosylation defect will be presented, with hypotonia, developmental delay and blindness and a pathogenic variant that was previously described in two patients. Method: Whole exome sequencing (WES) was performed, since the patient had no time to implement diagnostic algorithm for hypotonia etiology. Results: WES revealed a new pathogenic variant of homozygous c.993_1011del (p.Glu335Hisfs*55) frameshift variant of the FUK gene NM_145059 transcript. She had milder clinical manifestation than reported two patients. Conclusion: Congenital Defect of Glycosylation should be considered when the clinical findings cannot be explained by other known diseases, particularly in patients with multisystemic, predominantly neurological involvement. | en_US |
dc.identifier.citation | Özgün, N., & Şahin, Y. (2021). A case with congenital disorder of glycosylation with defective fucosylation 2 and new mutation in FUK gene. Brain & development, S0387-7604(21)00206-0. Advance online publication. | en_US |
dc.identifier.doi | 10.1016/j.braindev.2021.11.001 | en_US |
dc.identifier.pmid | 34802815 | en_US |
dc.identifier.scopus | 2-s2.0-85119433418 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.braindev.2021.11.001 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2280 | |
dc.identifier.wos | WOS:000752432400008 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Özgün, Nezir | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Brain and Development | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Congenital Defect of Glycosylation | en_US |
dc.subject | Developmental Delay | en_US |
dc.subject | Hypotonia | en_US |
dc.subject | Type2 Fucosylation Defect | en_US |
dc.title | A case with congenital disorder of glycosylation with defective fucosylation 2 and new mutation in FUK gene | en_US |
dc.type | Article | en_US |